Company intelligence / Profile preview

Strategy12 Consulting

Summit, New Jersey, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Strategy12 Consulting is a boutique strategic advisory firm dedicated to the life sciences, biotechnology, and pharmaceutical sectors. The company specializes in bridging the 'commercialization gap' for emerging biopharma organizations by providing expert guidance on market access, product launch planning, and portfolio prioritization. Strategy12 leverages deep industry expertise to help clients navigate complex regulatory and market dynamics, ensuring that therapeutic innovations reach their full commercial potential. Their services span from early-stage commercial assessments and due diligence to post-launch brand optimization and competitive positioning.

Industry: Consulting

Beyond the preview

Go deeper on Strategy12 Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Strategy12 Consulting.

Explore the full profile